Fig. 6From: 2D and 3D similarity landscape analysis identifies PARP as a novel off-target for the drug VatalanibImmunofluorescence of MCF-7 cell lines. Immunofluorescence of MCF-7 cell lines 24 h after treatment with increasing concentrations of Compound 1 (top) and Vatalanib (bottom). Accumulation of γH2AX foci in green, 4’,6’-diamino-2-phenylindole (DAPI) staining in blueBack to article page